Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study
- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing…
Supermicro, Intel and Micron Collaborate on Record-Breaking Results for the STAC-M3 Quantitative Trading Benchmark
The STAC-M3 measures time-series database performance used in algorithmic trading and backtesting…
Varonis Announces Third Quarter 2025 Financial Results
Annual recurring revenues increased 18% year-over-yearSaaS ARR as a percentage of total…
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…
Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care
Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in…
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
October 23, 2025 13:08 ET | Source: Progyny, Inc. NEW YORK, Oct.…
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
October 22, 2025 16:30 ET | Source: CVRx, Inc. MINNEAPOLIS, Oct. 22,…
Duck Creek Technologies Wins IDC FinTech Real Results Award for Insurance Transformation
Recognition highlights Duck Creek's measurable impact on HDFC ERGO's digital transformation journey…
AV-Comparatives Releases Latest Security Test Results for Enterprise and Consumer Markets
INNSBRUCK, Austria, Oct. 21, 2025 /PRNewswire/ -- Independent evaluations highlight trusted cybersecurity…
IO Biotech Presents Phase 3 Results for Cylembio plus KEYTRUDA (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025
October 20, 2025 02:30 ET | Source: IO Biotech Cylembio plus pembrolizumab…
